ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (5): 123-127.doi: 10.6040/j.issn.1673-3770.0.2022.444
• Original Article • Previous Articles Next Articles
ZHAO Hui, HUANG Chao, CUI Wenxuan, SI Mingwei, YANG Mengyao, WANG Hong, ZHOU Fang
CLC Number:
| [1] Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium[J]. Oncologist, 2011, 16(11): 1589-1599. doi:10.1634/theoncologist.2011-0210 [2] Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma[J]. Surv Ophthalmol, 2014, 59(5): 503-516. doi:10.1016/j.survophthal.2013.12.001 [3] 蒋婷婷, 李睿文, 刘师学, 等. 原发性玻璃体视网膜淋巴瘤: 10年诊治回顾[J]. 中华眼底病杂志, 2022(5): 376-381. doi:10.3760/cma.j.cn511434-20220310-00126 Jiang TT, Li RW, Liu SX, et al. The diagnosis and treatment of primary vitreoretinal lymphoma: 10 years of experience[J]. Chinese Journal of Ocular Fundus Diseases, 2022(5): 376-381.doi:10.3760/cma.j.cn511434-20220310-00126 [4] Pulido JS, Johnston PB, Nowakowski GS, et al. Correction to: the diagnosis and treatment of primary vitreoretinal lymphoma: a review[J]. Int J Retina Vitreous, 2018, 4: 22. doi:10.1186/s40942-018-0126-y [5] Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal(intraocular)lymphoma[J]. Discov Med, 2013, 15(81): 93-100. [6] Pulido JS, Johnston PB, Nowakowski GS, et al. The diagnosis and treatment of primary vitreoretinal lymphoma: a review[J]. Int J Retina Vitreous, 2018, 4: 18. doi:10.1186/s40942-018-0120-4 [7] Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma[J]. Arch Ophthalmol, 1997, 115(9): 1157-1160. doi:10.1001/archopht.1997.01100160327010 [8] Finger PT, Papp C, Latkany P, et al. Anterior chamber paracentesis cytology(cytospin technique)for the diagnosis of intraocular lymphoma[J]. Br J Ophthalmol, 2006, 90(6): 690-692. doi:10.1136/bjo.2005.087346 [9] Frenkel S, Pe'er J, Kaufman R, et al. The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma[J]. Acta Ophthalmol, 2020, 98(6): e668-e673. doi:10.1111/aos.14347 [10] Coupland SE, Hummel M, Müller HH, et al. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma[J]. Invest Ophthalmol Vis Sci, 2005, 46(10): 3507-3514. doi:10.1167/iovs.05-0401 [11] Tanaka R, Kaburaki T, Taoka K, et al. More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results: a prospective observational study[J]. Ocular Immunol Inflamm, 2022, 30(6): 1354-1360. doi:10.1080/09273948.2021.1873394 [12] Sehgal A, Pulido JS, Mashayekhi A, et al. Diagnosing vitreoretinal lymphomas-an analysis of the sensitivity of existing tools[J]. Cancers, 2022, 14(3): 598. doi:10.3390/cancers14030598 [13] 陈秀菊, 常青, 江睿, 等. 玻璃体腔注射甲氨蝶呤治疗玻璃体视网膜淋巴瘤14例[J]. 中华眼底病杂志, 2016, 32(4): 399-403. doi:10.3760/cma.j.issn.1005-1015.2016.04.013 CHEN Xiuju, CHANG Qing, JIANG Rui, et al. Intravitreal methotrexate chemotherapy in the treatment of 14 patients with priamary vitreoretinal lymphoma[J]. Chinese Journal of Ocular Fundus Diseases, 2016, 32(4): 399-403. doi:10.3760/cma.j.issn.1005-1015.2016.04.013 [14] 朱婕, 李喆, 徐敏, 等. 原发于中枢神经系统淋巴瘤的眼内淋巴瘤1例[J]. 中华眼底病杂志, 2022, 38(7): 601-603. doi:10.3760/cma.j.cn511434-20210824-00458 ZHU Jie, LI Zhe, XU Min, et al. Intraocular lymphoma with primary central nervous system lymphoma: a case report[J]. Chinese Journal of Ocular Fundus Diseases, 2022, 38(7): 601-603. doi:10.3760/cma.j.cn511434-20210824-00458 [15] Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience[J]. Br J Ophthalmol, 2008, 92(3): 383-388. doi:10.1136/bjo.2007.127928 [16] Castellino A, Pulido JS, Johnston PB, et al. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: a single center experience 1990-2018[J]. Am J Hematol, 2019, 94(3): 291-298. doi:10.1002/ajh.25350 [17] Bannwarth B, Péhourcq F, Schaeverbeke T, et al. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis[J]. Clin Pharmacokinet, 1996, 30(3): 194-210. doi:10.2165/00003088-199630030-00002 [18] Rizkalla K, Rodrigues S, Proulx A, et al. Primary intraocular lymphoma arising during methotrexate treatment of temporal arteritis[J]. Can J Ophthalmol, 2005,40(5):585-592. doi: 10.1016/S0008-4182(05)80050-X [19] Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma: case reports and a review[J]. Surv Ophthalmol, 2001, 45(6): 463-471. doi:10.1016/s0039-6257(01)00217-x [20] Gass JD, Trattler HL. Retinal artery obstruction and atheromas associated with non-Hodgkin's large cell lymphoma(reticulum cell sarcoma)[J]. Arch Ophthalmol, 1991, 109(8): 1134-1139. doi:10.1001/archopht.1991.01080080094039 [21] Gezer S, Vural B, Kirsavoglu M, et al. Branch retinal artery occlusion in a patient undergoing Methotrexate therapy for ectopic pregnancy: a case report[J]. J Pak Med Assoc, 2020, 70(2): 357-359. doi:10.5455/JPMA.14284 [22] Fierz AB, Sartoretti S, Thoelen AM. Optic neuropathy and central retinal artery occlusion in non-Hodgkin lymphoma[J]. J Neuroophthalmol, 2001, 21(2): 103-105. doi:10.1097/00041327-200106000-00009 [23] 赵兴贺, 樊明月, 窦训武, 等. 儿童原发扁桃体弥漫大B细胞淋巴瘤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 120-124. doi:10.6040/j.issn.1673-3770.0.2021.366 ZHAO Xinghe, FAN Mingyue, DOU Xunwu, et al. Primary large B-cell lymphoma of tonsil in children: a case report and document review[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 120-124. doi:10.6040/j.issn.1673-3770.0.2021.366 [24] Carbonell D, Mahajan S, Chee SP, et al. Consensus recommendations for the diagnosis of vitreoretinal lymphoma[J]. Ocul Immunol Inflamm, 2021, 29(3): 507-520. doi:10.1080/09273948.2021.1878233 [25] Habot-Wilner Z, Frenkel S, Pe'er J. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma- 20 years of experience[J]. Br J Haematol, 2021, 194(1): 92-100. doi:10.1111/bjh.17451 |
| [1] | ZHANG Xiaohan, WEI Li, YANG Kaili, CHEN Haiyan, LI Yansong, WANG Ping. Study on the change of OCTA and its correlation with visual acuity in patients with CSC before and after TCM syndrome differentiation and treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 115-122. |
| [2] | CHEN Zhuoyi, ZHENG Yiqing, YANG Haidi. Classification, pathogenesis, and treatment advances of chronic subjective tinnitus [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 1-12. |
| [3] | LI Lu, ZHAO Jie, ZHAO Bojun. Research progress on the pathogenesis and treatments of central serous chorioretinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 118-124. |
| [4] | ZHANG YuOverview,QU YiGuidance. Research progress on the pathogenesis and control of ocular toxoplasmosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 70-76. |
| [5] | SONG QingOverview,SONG XichengGuidance. Research progress of anlotinib combination therapy in cancer treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 106-112. |
| [6] | ZHANG Keren, LEI Chunyan, ZHANG Meixia. Floppy eyelid syndrome associated with obstructive sleep apnea: a case report [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 125-128. |
| [7] | SHI Anni, ZHANG Jiajia, BAI Peng, ZHANG Chongyang. Analysis of a therapeutic modality for sudden deafness utilizing neck acupuncture comprising seven lines of treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 103-107. |
| [8] | XIONG Panhui, SHEN Yang,YANG Yucheng. Advancements in the diagnosis and treatment of chronic sinusitis based on phenotypes and endotypes [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 15-19. |
| [9] | LIANG Xu,SHI Li. Research progress in biologic targeted drug therapy for chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 30-35. |
| [10] | GU Yu, WAN Xin,XIAO Zi'an. The interaction between neutrophils and eosinophils in chronic rhinosinusitis and the implications on treatment options [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 56-63. |
| [11] | ZENG Xianting, WANG Guangke, SUN Zhanwei, WU Tianyi, LI Shichao, WANG Weiwei. Postoperative efficacy of proton pump inhibitor in the treatment of difficult-to-treat rhinosinusitis with laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 189-194. |
| [12] | ZHANG Taoran, WANG Wei, LI Mingming, HUANG Yingxiang. Subfoveal choroidal thickness changes following intravitreal ranibizumab treatment in choroidal neovascularization due to pathological myopia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 68-71. |
| [13] | HUA Hongli, LI Song,TAO Zezhang. Research progress of artificial intelligence in the diagnosis and treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 113-119. |
| [14] | DI Yu,LI Ying. Research progress in the inflammatory reaction and anti-inflammatory treatments in dry eye [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 144-150. |
| [15] | CHEN Kun, LU Hui, HUANG Qi, LI Lei, MENG Guozhen, YANG Jun, HOU Dongming. Clinical diagnosis and treatment of congenital nasal sinus mass in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 81-85. |
|
||